The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-1.2% to $212.00
Predicted High$228.00at 2 months
Predicted Low$205.00at 5 months
Max Drawdown (predicted)-4.5%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 19, 2026 11:40 pm
Neutral
RVMD trends range-bound to
$212.00
(-1.2% from $214.66)
by Feb 2027.
ride-then-fade
ThesisRVMD is a pre-profit narrative RAS platform story with no value anchor, riding a risk-on tape and +116% six-month momentum. Near-term drift stays supported by the strong sentiment and monopoly-narrative bid, but value/quality lenses are deeply negative and any regime cooling or KRAS-adjacent data disappointment can compress this high-beta name meaningfully by year-end.
Invalidated ifBreak below $170 on volume, or a competitive KRAS/RAS clinical setback, or regime flip to risk-off would invalidate the drift-higher-then-fade path.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $214.66 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 19, 2026
—
$214.66at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Sep 2, 2026
$196.87–$232.45typical range · internal point $218.50
—
±8.3%
6/10
Momentum and risk-on regime sustain near-term drift higher
What actually happened:
closed $209.87
on Sep 1, 2026 = -2.2% vs the call
(predicted +1.8%)
· direction HIT
(called flat, was flat)
· off by 4.0 pp
· accuracy 8/10
· typical range ±8.3%:
inside the band
· S&P -1.0%
over the same window — lagged it
1 month
Sep 19, 2026
$188.87–$240.45typical range · internal point $223.00
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$0.00
(+0.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.